CIK 0001374690
- Non-accelerated filer
- Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203857670
- Phone
- +1 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- Open-market buys, last 90 days
- $392,144
- in 8 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$392,144. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-04-01 | McDonough Cameron Geoffrey Director | Grant or award · Stock Option (Right to Buy) | +6,100 | 6,100 | ||
| 2016-04-01 | Daniel Thomas O Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2016-04-01 | Daniel Thomas O Director | Grant or award · Stock Option (Right to Buy) | +3,841 | 3,841 | ||
| 2016-03-31 | Loustau Patrick President | Grant or award · Stock Option (Right to Buy) | +113,000 | 113,000 | ||
| 2016-03-31 | Loustau Patrick President | Grant or award · Stock Option (Right to Buy) | +56,500 | 56,500 | ||
| 2016-03-31 | Hughes Thomas E. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +249,000 | 249,000 | ||
| 2016-03-31 | Hughes Thomas E. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +124,500 | 124,500 | ||
| 2016-03-31 | Secor Alicia Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | −53,000 | 53,000 | ||
| 2016-03-31 | Secor Alicia Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | −26,500 | 26,500 | ||
| 2016-03-31 | Allen Patricia L Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +72,000 | 72,000 | ||
| 2016-03-31 | Allen Patricia L Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2016-03-31 | KIM DENNIS D Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2016-03-31 | KIM DENNIS D Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2016-02-12 | Flynn James E 10% owner | Purchase | +22,296 | $6.25 | $139K | 441,043 |
| 2016-02-12 | Flynn James E 10% owner | Purchase | +28,377 | $6.25 | $177K | 561,328 |
| 2016-02-12 | Flynn James E 10% owner | Purchase | +13,872 | $6.25 | $87K | 2,053,232 |
| 2016-02-11 | Flynn James E 10% owner | Purchase | +810 | $6.19 | $5K | 418,747 |
| 2016-02-11 | Flynn James E 10% owner | Purchase | +1,030 | $6.19 | $6K | 532,951 |
| 2016-02-11 | Flynn James E 10% owner | Purchase | +504 | $6.19 | $3K | 2,039,360 |
| 2016-02-10 | Flynn James E 10% owner | Purchase | +52,239 | $6.23 | $326K | 417,937 |
Page 12 of 15 · 296 trades